Outpost Medicine
Industry
- Pharmaceuticals
Latest on Outpost Medicine
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in
Financings Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3
IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Zephyrus Biosciences Inc. Bio-Techne acquired private research tools company Zephyrus Biosciences Inc. Zephyrus will be rolled up into Bi
IN VITRO DIAGNOSTICS Adarza Biosystems Inc. Adarza Biosystems Inc. raises $5mm in Series B round Adarza Biosystems Inc. raised $5mm in its Series B financing round led by Cultivation Capital,